Navidea Biopharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol: NAVB on OTC
Industry: In Vitro & In Vivo Diagnostic Substances
Location: 4995 Bradenton Avenue, Suite 240, Dublin, OH

There are no Buy or Sell transactions made by insiders since 3/4/2024

Navidea Biopharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
John K. Scott Jr.	Director, 10%+ Owner	$2.8M			Nov 27, 2023
Craig Dais	Chief Financial Officer	$85.7K			Nov 10, 2023
Jill Stefanelli	Director	$82.9K			Nov 16, 2023
Dana J. Moss	Director	$76.3K			Nov 16, 2023
Malcolm G. Witter	Director	$14.5K			Nov 30, 2022
Amit Bhalla	Director	$6.32K			Nov 30, 2022
L. Cappello	Director	$5.96K			Nov 30, 2022
Michael S. Rosol	Chief Medical Officer	$5.9K			Sep 9, 2022
Agnieszka Winkler	Director	$2.96K			Nov 15, 2021
Thomas F. Farb	Director	$2.94K			Nov 15, 2021
Joshua M. Wilson	Director	$2.64K			Nov 29, 2022
Sarah Kathryn Rouan	Director	$1.61K			Jun 30, 2021
Claudine Bruck	Director	$1.45K			Jun 30, 2021
Michel Mikhail	Chief Regulatory Officer				Nov 15, 2021

Showing 1 to 14 of 14 entries

Recent Insider Transactions by Companies or Individuals for Navidea Biopharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.